Adjusted for age, sex, and years of education, there was a heightened aperiodic component in aMCI compared to the naMCI individuals observed in the APOE4 carriers, possibly indicative of the effects of APOE4 on AD-related symptoms. The gene discussed is APOE; the disease is Alzheimer disease.